Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

Bernard Zinman(Mount Sinai Hospital), Kuninobu Takai, Vanita R. Aroda(Brigham and Women's Hospital), Sophie Borot, Nikolaοs Tentolouris, G. Fradet, Αlexandra Bargiota(University of Thessaly), Shehla Shaikh, Neeraj Manikath, Takashi Sasaki, Daniel Landry, Yashdeep Gupta, Vincent Woo, Viswanathan Mohan(Madras Diabetes Research Foundation), P. Monguillon, Banshi Saboo(Diabetes Care & Hormone Clinic), John B. Buse(Unknown), Mads Jeppe Tarp-Johansen(Novo Nordisk (Denmark)), Pierre Gourdy(Université Toulouse III - Paul Sabatier), Arihiro Kiyosue(Minamiaoyama Eye Clinic), Jean-Francois Thuan, Eleni Bekiari(Aristotle University of Thessaloniki), Andreas Melidonis, Shuichi Fukuda, Pierre Sérusclat, Harpreet S. Bajaj, Eiichi Araki(Kumamoto Health Science University), Sameh Fikry, Takeshi Osonoi(Centre for Advanced Study), D. Gouet, Søren T. Hoff(Novo Nordisk (Denmark)), V. Tsimichodimos, Yumiko Ide, Arnaud Monier, Yukiko Onishi(The Institute of Medical Science, Asahi Life Foundation), John Doupis(Athens Medical Center), Sanjay Agarwal, Sanjay Chatterjee, Stewart B. Harris(Western University), Seiki Wada, David Caplan, Kiyokazu Matoba, Arpandev Bhattacharyya, Bertrand Cariou(Institut du Thorax), Sunil Kumar, Karen Boje Pedersen(Novo Nordisk (Denmark))
Diabetes Care
July 10, 2019
Cited by 282


Related Papers